Xponance’s Arcellx ACLX Stock Holding History

Xponance’s Portfolio ACLX Stock Details ACLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,524	Closed	-$405K	–	1842
2026 Q1	$405K	Buy	+3,524	New	+$311K	﹤0.01%	1104
2025 Q4	–	Sell	-2,694	Closed	-$221K	–	1571
2025 Q3	$221K	Buy	+2,694	New	+$194K	﹤0.01%	1317
2025 Q2	–	Sell	-3,278	Closed	-$215K	–	1509
2025 Q1	$215K	Buy	3,278 +190	+6%	+$12.9K	﹤0.01%	1245
2024 Q4	$237K	Buy	3,088 +244	+9%	+$21.1K	﹤0.01%	1228
2024 Q3	$238K	Buy	+2,844	New	+$189K	﹤0.01%	1162

Other funds holding ACLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Xponance's ACLX Position: Q2 2026 in Review

Xponance sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 3,524 shares — an estimated $405K sold.

Xponance first reported a position in ACLX in Q3 2024 and held it in 5 quarters. The position peaked at $405K in Q1 2026. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.

Xponance reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
Xponance sold 3,524 Arcellx shares in Q2 2026, an estimated $405K.
Xponance first reported a position in Arcellx in Q3 2024 and held it in 5 quarters.
Xponance's Arcellx position peaked at $405K in Q1 2026.
2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.